Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2024-12-22T15:08:28.113Z Has data issue: false hasContentIssue false
  • English
  • Français

Longitudinal study of toxoplasma seroprevalence in South Yorkshire

Published online by Cambridge University Press:  15 May 2009

J. Walker ,
D. J. Nokes  and
R. Jennings
J. Walker
Affiliation:
Parasite Epidemiology Research Group, Department of Biology, Imperial College, Prince Consort Road, London SW7 2BB
D. J. Nokes
Affiliation:
Parasite Epidemiology Research Group, Department of Biology, Imperial College, Prince Consort Road, London SW7 2BB
R. Jennings
Affiliation:
Section of Virology, Department of Experimental and Clinical Microbiology, Sheffield University Medical School, Sheffield
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Serum samples collected from individuals of a wide range of ages in South Yorkshire between 1969 and 1990 provided the basis for a longitudinal seroprevalence survey of Toxoplasma gondii antibodies. Sera numbering 3868 were screened for T. gondii specific antibodies using a commercial latex agglutination test. The resultant temporal series of serological profiles revealed a rise, with age, in seroprevalence, the rate of which showed a decrease through time. A plateau of around 40–50% prevalence was attained by the 41- to 45-year age-class in 1969 which was not approached until the 66- to 70-year class in the 1988–90 data set. This trend for decline in seroprevalence was confirmed by statistical analysis for the age range 21–60 years. These results may be indicative of a decrease in the rate of toxoplasma exposure in this study community over the 20-year period. The survey of 1988–90 provides a base-line profile of present-day seroprevalence in which 11 % of individuals in the age range 16–45 years (roughly corresponding to the childbearing age-range) show evidence of past infection. The representative nature of the serum collection and public-health implications of these results are discussed.

Type
Research Article
Information
Epidemiology & Infection , Volume 108 , Issue 1 , February 1992 , pp. 99 - 106
Copyright
Copyright © Cambridge University Press 1992

References

REFERENCES

1.Williams, KAB, Scott, JM, McFarlane, DE, Williamson, JMW, Elias-Jones, TF, Williams, H. Congenital toxoplasmosis: a prospective survey in the West of Scotland. J Infect 1981; 3: 219–29.CrossRefGoogle ScholarPubMed
2.Koppe, JG, Loewer-Sieger, DH, De Roever-Bonnet, H. Results of 20–year follow-up of congenital toxoplasmosis. Lancet 1988; I: 254–6.Google Scholar
3.Hall, S. Congenital toxoplasmosis in England, Wales and Northern Ireland: some epidemiological problems. BMJ 1983; 287: 453–55.CrossRefGoogle ScholarPubMed
4.Wreghitt, TG, Gray, JJ, Balfour, AH. Problems with serological diagnosis of Toxoplasma gondii infections in heart transplant patients. J Clin Pathol 1986; 39: 1135–9.CrossRefGoogle Scholar
5.Luft, B, Remington, JS. Toxoplasma encephalitis. J Infect Dis 1988; 157: 1–6.CrossRefGoogle Scholar
6.Fuith, LC, Reibnegger, G, Honlinger, M, Wachter, H. Screening for toxoplasmosis in pregnancy. Lancet 1988; II: 1196.CrossRefGoogle Scholar
7.Joynson, DHM, Payne, R. Screening for toxoplasma in pregnancy. Lancet 1988, II: 795–6.CrossRefGoogle Scholar
8.Johnson, J, Duffy, K, New, L, Holliman, RE, Chessum, BS, Fleck, DG. Direct agglutination test and other assays for measuring antibodies to Toxoplasma gondii. J Clin Pathol 1989; 42: 536–41.CrossRefGoogle ScholarPubMed
9.Joss, AWS, Chatterton, JMW, Ho-Yen, DO. Congenital tongenital toxoplasmosis: to sereen or not to sereen? Public Health 1990; 104: 9–20.Google Scholar
10.Joss, AWS, Skinner, LJ, Chatterton, JMW, Cubie, HA, Pryde, JFD, Campbell, JD. Toxoplasmosis: effectiveness of enzyme immunoassay screeay screening. Med Lab Sci 1989; 46: 107–12.Google ScholarPubMed
11.Henderson, JB, Beattie, CP, Hale, EG, Wright, J. The vealuation of new services: Possibilities for preventing congenital toxoplasmosis. Int J Epidemiol 1984; 13: 133–44.CrossRefGoogle ScholarPubMed
12.Hall, SM. Toxoplasmosis. J Small Anim Pract 1986; 27: 705–16.CrossRefGoogle Scholar
13.Joss, AWL, Skinner, LJ, Chatterton, JMW, Crisholm, SM, Williams, HD, Ho-Yen, DO. Simultaneous serological screening for congenital cytomegalovirus and toxoplasma infection.Publ Hlth 1988; 102: 409–17.CrossRefGoogle ScholarPubMed
14.Ahlfors, K, Borjeson, M, Huldt, G, Forsberg, E. Incidence of toxoplasmosis in pregnant women in the city of Malmo, Sweden. Scand J Infect Dis 1989; 21: 315–21.CrossRefGoogle ScholarPubMed
15.Papoz, L, Simondon, F, Saurin, W, Sarmini, H. A simple model relevant to toxoplasmosis applied to epidemiologic results in France. Am J Epidemiol 1986; 123: 154–61.CrossRefGoogle ScholarPubMed
16.Ades, AE, Peckham, CS, Dale, GE, Best, JM, Jeansson, S. Prevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women, and estimated rates of infection. J Epidemiol Comm Hlth 1989; 43: 53–60.CrossRefGoogle ScholarPubMed
17.Schenzle, D, Dietz, K, Frosner, GG. Antibody against hepatitis A in seven European countries. II. Statistical analysis of cross-sectional surveys. Am J Epidemiol 1979; 110: 70–6.CrossRefGoogle Scholar
18.Fleck, DG.Toxoplasmosis. Publ Hlth 1969; 83: 131–5.CrossRefGoogle ScholarPubMed
19.Kobayashi, A, Hirai, N, Suzuki, Y, Nishikawa, H, Watanabe, N. Evaluation of a commercial toxoplasma latex agglutination test. Jap J Parasitol 1977; 26: 175–80.Google Scholar
20.Balfour, AH, Fleck, DH, Hughs, HPA, Sharp, D. Comparative study of three tests (dye test, indirect haemagglutination test, latex agglutination test) for the detection of antibodies to Toxoplasma gondii in human sera. J Clin Pathol 1982; 35: 228–32.CrossRefGoogle ScholarPubMed
21.Armitage, P, Berry, G. Statististical methods in medical research, 2nd ed.Oxford: Blackweell Scientific Publications, 1988.Google Scholar
22.Fleck, DG. The serology of toxoplasmosis. MD Thesis 1961, University of London.Google Scholar
23.Holliman, RE. Serological study of the prevalence of toxoplasmosis in asymptomatic patients infected with human immunodeficiency virus. Epidemiol Infect 1990; 105: 415–8.CrossRefGoogle ScholarPubMed